Kukje Pharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 15, 2022 at 09:17 pm
Share
Kukje Pharma Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 32,241.18 million compared to KRW 29,626.68 million a year ago. Net income was KRW 1,187.12 million compared to KRW 126.59 million a year ago. Basic earnings per share from continuing operations was KRW 59.0476 compared to KRW 6.3492 a year ago. Diluted earnings per share from continuing operations was KRW 59.0476 compared to KRW 6.3492 a year ago. Basic earnings per share was KRW 59.0476 compared to KRW 6.6667 a year ago.
For the six months, sales was KRW 65,491.94 million compared to KRW 57,010.55 million a year ago. Net income was KRW 3,333.65 million compared to KRW 979.09 million a year ago. Basic earnings per share from continuing operations was KRW 164.7619 compared to KRW 48.5714 a year ago. Diluted earnings per share from continuing operations was KRW 164.7619 compared to KRW 48.5714 a year ago. Basic earnings per share was KRW 164.7619 compared to KRW 48.5714 a year ago.
Kukje Pharma Co., Ltd, formerly Kukje Pharma Ind. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products are finished products, such as antibiotics, other antibiotics for injection, antifungal and antiviral agents, agents for gastrointestinal tract and liver, muscle relaxants, anti-osteoporotics, corticosteroids, agents for cardiovascular and endocrine systems, ophthalmic agents, remedies for central nervous system (CNS) disorders, remedies for urinary systems, antihistamines, antitussives, cough and cold remedies, non-steroidal anti inflammatory drugs (NSAIDs), antitussive, cough and cold remedies, as well as other over-the-counter (OTC) drugs. It also provides raw materials, such as ceftriaxone sodium sterile, cefuroxime axetil, ceftezole sodium sterile, cefminox sodium sterile, cefuroxime sodium sterile and others.